RIP1/RIP3/MLKL activator 1 (Compound 6i) is a potent anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway. RIP1/RIP3/MLKL activator 1 exerts acceptable BBB permeability In Vitro RIP1/RIP3/MLKL activator 1 (Compound 6i) (96 h) shows antiproliferative activities in human glioma cell lines. RIP1/RIP3/MLKL activator 1 (0-4 µM, 0-72 h) exhibits remarkable antiproliferative activity for U251 cells in a time- and concentration-dependent manner. RIP1/RIP3/MLKL activator 1 (10 µM, 0-72 h) shows acceptable stability. RIP1/RIP3/MLKL activator 1 (0-2 µM, 24 h) effectively inhibits the migration of U251 cells. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway, and induces mitochondrial depolarization in U251 cells. RIP1/RIP3/MLKL activator 1 could not induce apoptosis in U251 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: A172, LN229, U87, U251 and L02 cell lines Concentration: 0-4 µM for U251 cells Incubation Time: 96 h; 24, 48, and 72 h for U251 cells Result: Showed antiproliferative activity with IC 50 values of 3.03 ± 0.70, 1.78 ± 0.79, 1.22 ± 0.89, 0.94 ± 0.45, and 0.99 ± 0.46 µM against A172, LN229, U87, U251 and L02 cells, respectively. Time- and concentration-dependently inhibited the growth in U251 cells. Western Blot AnalysisCell Line: U251 Concentration: 0, 0.5, 1, 2, and 4 µM Incubation Time: 24 or 48 h Result: Concentration-dependently upregulated the expression of p-RIP1, RIP1, p-RIP3, RIP3, p-MLKL, and MLKL at 24 or 48 h. In Vivo RIP1/RIP3/MLKL activator 1 (Compound 6i) (2.50 ng/tail; i.v.; 48 h) inhibits U251 cell proliferation in vivo and exerts acceptable BBB permeability . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Zebrafish wide-type AB strain; 200 CM-DiI labeled U251 cells were transplanted into yolk sac of each wild-type zebrafish embryos at 2 dpf (2 days postfertilization) Dosage: 2.50 ng/tail Administration: Microinjection; 48 h Result: Remarkably reduced the U251 xenografts fluorescence intensity. Form:Solid IC50& Target:RIP1, RIP3, MLKL
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
RIP1/RIP3/MLKL activator 1
CAS number：2682850-41-3 molecular formula：C43H56N4O3
overview
compound introduction
Specs
| Chinese alias | RIP1/RIP3/MLKL 激活剂 1 | ||
| English alias | - | ||
| CAS number | 2682850-41-3 | molecular formula | C43H56N4O3 |
| molecular weight | 676.93 g/mol | Exact mass | ≥97% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
